85,747 Shares in Aspen Aerogels, Inc. (NYSE:ASPN) Acquired by XTX Topco Ltd

XTX Topco Ltd bought a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 85,747 shares of the construction company’s stock, valued at approximately $1,019,000. XTX Topco Ltd owned approximately 0.10% of Aspen Aerogels as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ASPN. Morse Asset Management Inc acquired a new stake in shares of Aspen Aerogels in the third quarter valued at $264,000. AlphaQuest LLC increased its holdings in Aspen Aerogels by 54.0% during the 4th quarter. AlphaQuest LLC now owns 11,395 shares of the construction company’s stock worth $135,000 after purchasing an additional 3,998 shares during the period. KLP Kapitalforvaltning AS acquired a new stake in Aspen Aerogels in the 4th quarter valued at about $164,000. Journey Strategic Wealth LLC purchased a new position in shares of Aspen Aerogels in the 4th quarter valued at about $178,000. Finally, Y Intercept Hong Kong Ltd acquired a new position in shares of Aspen Aerogels during the third quarter worth about $420,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently weighed in on ASPN. Barclays decreased their price target on shares of Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating for the company in a research note on Wednesday, February 19th. Craig Hallum decreased their price objective on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating for the company in a research report on Friday, February 14th. TD Cowen raised Aspen Aerogels to a “strong-buy” rating in a report on Tuesday, March 11th. StockNews.com raised Aspen Aerogels to a “sell” rating in a report on Wednesday, February 19th. Finally, Canaccord Genuity Group lowered their price objective on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a research report on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $19.11.

Aspen Aerogels Stock Down 2.4 %

Aspen Aerogels stock opened at $5.19 on Wednesday. The company has a market capitalization of $425.71 million, a P/E ratio of 32.41 and a beta of 2.35. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. Aspen Aerogels, Inc. has a fifty-two week low of $4.80 and a fifty-two week high of $33.15. The stock has a 50-day simple moving average of $7.34 and a 200-day simple moving average of $12.78.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. Equities research analysts expect that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.